Cell Biology of HIV: From Immune Cells Dysregulation to HIV-Related Cardiovascular Diseases
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Cardiovascular System".
Deadline for manuscript submissions: closed (15 February 2023) | Viewed by 5700
Special Issue Editor
Special Issue Information
Dear Colleagues,
Human immunodeficiency virus (HIV) remains a worldwide burden despite available treatments, such as antiretroviral therapy (ART). ART can durably suppress HIV replication; however, it is not curative as integrated HIV genome persists within CD4+ T cells and perhaps other immune cells. The virus induces dysregulations in major immune cells (T follicular helper (Tfh), CD8+ T cells, macrophages, dendritic cells (DC) from myeloid to plasmacytoid (pDC)) and uses cell-to-cell contact for transmission and dissemination. Thus, HIV infection is accompanied by persistent immune activation despite effective ART and maintained viral suppression. This constant activation of both the innate and adaptive immune systems results in low grade inflammation, leading to circulating proinflammatory and profibrotic cytokines, which may contribute to cardiac and endothelial dysfunction, hypercoagulation, and fibrotic remodeling and increase the risk of cardiovascular disease (CVD) onset in people living with HIV. In fact, HIV+ patients with access to modern ART face a two-fold increased risk of heart failure as compared to non-HIV-infected individuals.
This Special Issue will examine how HIV interferes with immune cell subsets (Tfh, CD8+ T Cells, B cells and myeloid cells) activity in vitro and in vivo after traditional ART or early onset of ART during acute HIV infection. Finally, the special issue will emphasize how HIV interferes with cardiomyocytes function in vitro and how HIV-impaired immune cells activity may lead to higher risk of CVD.
Dr. Virginie Tardif
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HIV-dysregulated immunity (Tfh, DC, B cells, myeloid cells)
- cell infection
- transmission
- acute HIV
- chronic HIV
- HIV-related CVD
- HIV-cardiotoxicity
